Wockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...

India must reform its tax system and streamline clearances to attract global investments moving away from China. Economist Arvind Virmani e...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

On May 4, China said it had removed import duties on as many as 28 medicines, but the need for lengthy trials and approvals has dampened en...

He has been a member of Ranbaxy's executive committee and has held positions on boards of various overseas subsidiaries of the pharma major.

The pharma sector, estimated to be around Rs 1.5 lakh cr, recorded single digit growth for the first time in many years on account of deepe...

The DIPP said current norms must lay down the foundation of what should be the nature of Indian drug companies in the long term.

With no let up in multinationals seeking nod to acquire stake in Indian pharma firms despite government putting norms to check it.

While the company's performance in the June quarter was strong sequentially, it will be interesting to see GSK's strategies to overcome the...

Worried over the spate of takeover of Indian pharmaceutical companies by multinational firms, the government has set up a panel to study th...

Leading domestic drugmakers have decided to collectively challenge frivolous patent applications filed by multinationals in India under the...

India on Wednesday complained to the UN intellectual property rights body, WIPO, that some multinational firms have launched campaign again...

India, along with Brazil, will lodge a complaint with the WTO against the European Union, alleging that Europe-based multinational pharmace...

The health ministry will put on hold its plans to grant permissions to multinational pharma firms for conducting phase I clinical trials of...

Domestic drug firm Sun Pharmaceutical, which had acquired Israel-based Taro Pharma for 455 million dollar last year, today said the Israel-...

A third of Asia’s drugmakers want to buy other pharmaceutical companies as they seek a bigger share of the $643 billion global market, a ne...

India and China will drive the growth in Asia's pharmaceutical industry as the continent gears up to become the centre of the global pharma...